These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9245192

  • 21. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
    Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pecquery R, Launay JM, Perez-Diaz F, Spreux-Varoquaux O.
    Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
    [Abstract] [Full Text] [Related]

  • 22. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
    Theodorakis GN, Markianos M, Zarvalis E, Livanis EG, Flevari P, Kremastinos DT.
    J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
    [Abstract] [Full Text] [Related]

  • 23. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B.
    Int Psychogeriatr; 1996 Jul; 8(1):83-102. PubMed ID: 8805090
    [Abstract] [Full Text] [Related]

  • 24. Abnormal neuroendocrine responsivity to clomipramine in depression.
    Golden RN, Ruegg R, Brown TM, Haggerty J, Garbutt JC, Pedersen CA, Evans DL.
    Psychopharmacol Bull; 1990 Jul; 26(3):317-20. PubMed ID: 2125736
    [Abstract] [Full Text] [Related]

  • 25. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN, Hsiao JK, Lane E, Ekstrom D, Rogers S, Hicks R, Potter WZ.
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [Abstract] [Full Text] [Related]

  • 26. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment.
    Leatherman ME, Ekstrom RD, Corrigan M, Carson SW, Mason G, Golden RN.
    Psychopharmacol Bull; 1993 Jan; 29(2):149-54. PubMed ID: 8290659
    [Abstract] [Full Text] [Related]

  • 27. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS, Lecić D, Doder M, Marinković J, Filipović S.
    Biol Psychiatry; 1996 Oct 15; 40(8):769-75. PubMed ID: 8894070
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM, O'Keane V, Murray RM.
    Br J Psychiatry; 1996 Jan 15; 168(1):57-60. PubMed ID: 8770429
    [Abstract] [Full Text] [Related]

  • 29. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B, Yagmur MJ, Gropp C, Newman M, Lerer B.
    Biol Psychiatry; 1992 May 15; 31(10):975-83. PubMed ID: 1511080
    [Abstract] [Full Text] [Related]

  • 30. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH.
    Am J Psychiatry; 1994 Nov 15; 151(11):1626-30. PubMed ID: 7943451
    [Abstract] [Full Text] [Related]

  • 31. The effects of intravenous clomipramine on neurohormones in normal subjects.
    Golden RN, Hsiao J, Lane E, Hicks R, Rogers S, Potter WZ.
    J Clin Endocrinol Metab; 1989 Mar 15; 68(3):632-7. PubMed ID: 2537340
    [Abstract] [Full Text] [Related]

  • 32. Hypersensitivity of the corticotropic axis to the serotoninergic agent clomipramine in obese women.
    Laferrère B, Lahlou N, Saltiel H, Roger M, Basdevant A, Oppert JM, Guy-Grand B.
    Obes Res; 1994 Jul 15; 2(4):328-36. PubMed ID: 16353581
    [Abstract] [Full Text] [Related]

  • 33. Recovery from major depression is not associated with normalization of serotonergic function.
    Flory JD, Mann JJ, Manuck SB, Muldoon MF.
    Biol Psychiatry; 1998 Mar 01; 43(5):320-6. PubMed ID: 9513746
    [Abstract] [Full Text] [Related]

  • 34. Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.
    Heninger GR, Charney DS, Sternberg DE.
    Arch Gen Psychiatry; 1984 Apr 01; 41(4):398-402. PubMed ID: 6703856
    [Abstract] [Full Text] [Related]

  • 35. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Apr 01; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R, Quested DJ, Laver D, Harrison PJ, Cowen PJ.
    Psychopharmacology (Berl); 2000 May 01; 150(1):120-2. PubMed ID: 10867985
    [Abstract] [Full Text] [Related]

  • 38. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P.
    Br J Psychiatry; 1990 Oct 01; 157():551-7. PubMed ID: 2131137
    [Abstract] [Full Text] [Related]

  • 39. Are gender differences important for the clinical effects of antidepressants?
    Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P, Danish University Antidepressant Group.
    Am J Psychiatry; 2003 Sep 01; 160(9):1643-50. PubMed ID: 12944340
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.